Viridian Therapeutics
VRDN
$13.45
Share price
-8.07%
Change (1 day)
-41.29%
Change (1 year)
Categories
Earnings for Viridian Therapeutics (VRDN)
Earnings in 2023 (TTM): -$0.24 B
According to Viridian Therapeutics's latest financial reports the company's current earnings (TTM) are -$0.24 B. In 2022 the company made an earning of -$0.13 B a decrease over its 2021 earnings that were of -$79.47 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Viridian Therapeutics from 2013 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$0.24 B | 82.31% |
| 2022 | -$0.13 B | 62.82% |
| 2021 | -$79.47 M | -27.89% |
| 2020 | -$0.12 B | 168.55% |
| 2019 | -$41.04 M | 28.93% |
| 2018 | -$31.83 M | 21.82% |
| 2017 | -$26.13 M | 107.72% |
| 2016 | -$12.58 M | 12.44% |
| 2015 | -$11.19 M | 62.91% |
| 2014 | -$6.87 M | 3399.7% |
| 2013 | -$0.2 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$0.12 B | -53.04% | 🇺🇸 USA |